MedTrace Logo

Evaluation of Airway Pressure Release Ventilation in COVID-19 ARDS

NCT04386369 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2020-09-14

No results posted yet for this study

Summary

The 2020 pandemic of the coronavirus (SARS-CoV2) has lead to an increase in ARDS cases requiring invasive mechanical ventilation in the ICU (Intensive Care Unit).

The investigators hypothesize that airway pressure release ventilation (APRV) could be beneficial in patients with ARDS secondary to SARS-COV2 viral pneumonia.

Conditions

  • ARDS
  • COVID19

Interventions

OTHER

Airway pressure release ventilation

Ventilator management strategy

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Matthieu Koszutski, MD · CHRU de NANCY, Médecine Intensive et Réanimation Brabois

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-15
Primary Completion
2020-06-01
Completion
2020-06-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04386369 on ClinicalTrials.gov